LuX-Valve Plus Successfully Completed The First Clinical Implantation in Brazil
Jenscare Scientific Co., Ltd.
dedicated to become a global leader in innovative solutions for structural heart diseases
We are pleased to share that recently, the first clinical implantation of LuX-Valve Plus, our proprietary transjugular tricuspid valve replacement product, has been successfully completed at Rede D’ OR Hospital in Brazil. The clinical interventional procedure was smooth. Immediately after the operation, it was shown that the implanted valve in the patient was stable, without regurgitation or paravalvular leakage, and additionally the mitral valve regurgitation had also been alleviated. The patient's clinical performance, cardiac function and quality of life improved significantly after the operation.